A Scatturin
Overview
Explore the profile of A Scatturin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
107
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vertuani G, Boggian M, Breveglieri A, Cavicchioni G, Spisani S, Scatturin A
Amino Acids
. 2013 Nov;
9(4):375-83.
PMID: 24178885
In order to investigate the proper peptide backbone conformation able to elicit a biological activity, HCO-Met-Pro-Phe-OMe, HCO-Met-Ψ[COO]Leu-Phe-OMe, and HCO-Met-OLeu-Phe-OMe, analogues of the prototypical chemotactic peptide HCO-Met-Leu-Phe-OMe, were studied by CD...
2.
Dalpiaz A, Mezzena M, Scatturin A, Scalia S
Int J Pharm
. 2008 Jan;
355(1-2):81-6.
PMID: 18178347
The objective of this study was to prepare solid lipid microparticles (SLMs) loaded with the polar adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA). The microparticles were produced by the conventional hot...
3.
Dalpiaz A, Filosa R, de Caprariis P, Conte G, Bortolotti F, Biondi C, et al.
Int J Pharm
. 2006 Dec;
336(1):133-9.
PMID: 17184941
We have previously demonstrated that dopamine conjugation to glucose allows it to induce therapeutic effects against Parkinson's disease after intravenous administration. In this paper we demonstrate that, unlike dopamine, the...
4.
Cortesi R, Argnani R, Esposito E, Dalpiaz A, Scatturin A, Bortolotti F, et al.
Int J Pharm
. 2006 Apr;
317(1):90-100.
PMID: 16600535
In the present study the preparation, characterization and activity of cationic liposomes containing the secretory form of herpes simplex virus type 1 (HSV-1) glycoprotein B (gB1s) or two related polylysine...
5.
Leo E, Contado C, Bortolotti F, Pavan B, Scatturin A, Tosi G, et al.
Int J Pharm
. 2005 Nov;
307(1):103-13.
PMID: 16289882
The prodrug 5'-octanoyl-CPA (Oct-CPA) of the antiischemic N6-cyclopentyladenosine (CPA) has been encapsulated by nanoprecipitation in poly(lactic acid) nanoparticles, which have been recovered by gel-filtration, ultra-centrifugation or dialysis. We have analysed...
6.
Dalpiaz A, Pavan B, Scaglianti M, Vitali F, Bortolotti F, Biondi C, et al.
Int J Pharm
. 2005 Feb;
291(1-2):171-81.
PMID: 15707744
Diclofenac (Diclo), its ascorbic acid (AA) or 6-amino-AA (AA-NH2) pro-drugs (AA-Diclo or AA-NH-Diclo) were prepared and evaluated on human retinal pigment epithelium (HRPE) cells to investigate their ability to interact...
7.
Dalpiaz A, Scatturin A, Pavan B, Biondi C, Vandelli M, Forni F
Int J Pharm
. 2002 Aug;
242(1-2):115-20.
PMID: 12176233
We report a preliminary study evaluating the encapsulation modalities in microparticles of the antiischemic drug N(6)-cyclopentyladenosine (CPA). The effects of release systems have been evaluated on the stability in human...
8.
Dalpiaz A, Scatturin A, Pavan B, Biondi C, Vandelli M, Forni F
J Control Release
. 2001 Aug;
73(2-3):303-13.
PMID: 11516507
A study concerning the feasibility of microsphere use as sustained delivery systems for N(6)-cyclopentyladenosine (CPA) administration has been performed. The release of this drug and the related stability effects in...
9.
Synthesis and study of 5'-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist
Dalpiaz A, Scatturin A, Menegatti E, Bortolotti F, Pavan B, Biondi C, et al.
Pharm Res
. 2001 Jul;
18(4):531-6.
PMID: 11451042
Purpose: A series of 5'-esters of N6-cyclopentyladenosine (CPA) were prepared with the aim to improve stability and bioavailability of selective A1 agonists. Log P values, stability, affinity, and activity toward...
10.
Dalpiaz A, Scatturin A, Vertuani G, Pecoraro R, Borea P, Varani K, et al.
Eur J Pharmacol
. 2001 Feb;
411(3):327-33.
PMID: 11164392
The biological action of a series of Met-Ile-Phe-Leu analogues was analyzed on human neutrophils, to evaluate their ability to interact with formylpeptide receptors and to induce the related neutrophil responses....